Exact Mass: 295.1485

Exact Mass Matches: 295.1485

Found 169 metabolites which its exact mass value is equals to given mass value 295.1485, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Butralin

N-(butan-2-yl)-4-tert-butyl-2,6-dinitroaniline

C14H21N3O4 (295.1532)


CONFIDENCE standard compound; INTERNAL_ID 277; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10587; ORIGINAL_PRECURSOR_SCAN_NO 10584 CONFIDENCE standard compound; INTERNAL_ID 277; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10578; ORIGINAL_PRECURSOR_SCAN_NO 10575 CONFIDENCE standard compound; INTERNAL_ID 277; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10538; ORIGINAL_PRECURSOR_SCAN_NO 10536 CONFIDENCE standard compound; INTERNAL_ID 277; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10568; ORIGINAL_PRECURSOR_SCAN_NO 10564 CONFIDENCE standard compound; INTERNAL_ID 277; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10608; ORIGINAL_PRECURSOR_SCAN_NO 10604 CONFIDENCE standard compound; INTERNAL_ID 277; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10617; ORIGINAL_PRECURSOR_SCAN_NO 10612

   

(E)-Herclavine

(2E)-N-[2-(4-methoxyphenyl)ethyl]-N-methyl-3-phenylprop-2-enamide

C19H21NO2 (295.1572)


(E)-Herclavine is found in herbs and spices. (E)-Herclavine is an alkaloid from the bark of Zanthoxylum clava-herculis (Hercules club

   

Doxepin N-oxide

N,N-dimethyl-3-[(2E)-9-oxatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene]propanamine oxide

C19H21NO2 (295.1572)


Doxepin N-oxide (CAS: 22684-91-9) is a metabolite of doxepin. Doxepin is a psychotropic agent with tricyclic antidepressant and anxiolytic properties, known under many brand-names such as Aponal, Adapine, Doxal, Deptran, Sinquan, and Sinequan. As doxepin hydrochloride, it is the active ingredient in cream-based preparations (Zonalon and Xepin) for the treatment of dermatological itch (Wikipedia).

   

(E)-2-hydroxydoxepin

(2Z)-2-[3-(dimethylamino)propylidene]-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-5-ol

C19H21NO2 (295.1572)


(E)-2-hydroxydoxepin is a metabolite of doxepin. Doxepin is a psychotropic agent with tricyclic antidepressant and anxiolytic properties, known under many brand-names such as Aponal, the original preparation by Boehringer-Mannheim, now part of the Roche group; Adapine, Doxal, Deptran, Sinquan and Sinequan. As doxepin hydrochloride, it is the active ingredient in cream-based preparations (Zonalon and Xepin) for the treatment of dermatological itch. (Wikipedia)

   

1,2-Dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline

15,16-dimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaene

C19H21NO2 (295.1572)


   

Cyclohexyl biphenyl-3-ylcarbamate

cyclohexyl N-{[1,1-biphenyl]-3-yl}carbamate

C19H21NO2 (295.1572)


URB602 is a selective monoacylglycerol lipase (MGL) inhibitor, which inhibits rat brain MGL with IC50 of 28±4 μM through a noncompetitive mechanism.

   

Dothiepin

dimethyl(3-{9-thiatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-2-ylidene}propyl)amine

C19H21NS (295.1395)


   

2-[[2-(4-Hydroxyphenyl)ethylamino]methyl]-3,4-dihydro-2H-naphthalen-1-one

2-({[2-(4-hydroxyphenyl)ethyl]amino}methyl)-1,2,3,4-tetrahydronaphthalen-1-one

C19H21NO2 (295.1572)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists

   

levo-tetrahydropalmatine

9,10-Dimethoxy-5,6,13,13a-tetrahydro-8H-dibenzo[a,g]quinolizine

C19H21NO2 (295.1572)


   

N-n-Propylnorapomorphine

10-propyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,13,15-hexaene-3,4-diol

C19H21NO2 (295.1572)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

Pizotifen

1-methyl-4-{6-thiatricyclo[8.4.0.0³,⁷]tetradeca-1(14),3(7),4,10,12-pentaen-2-ylidene}piperidine

C19H21NS (295.1395)


D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D002491 - Central Nervous System Agents > D000700 - Analgesics Pizotifen (Pizotyline) is a potent 5-HT2 receptor antagonist, with a high affinity for 5-HT1C binding site.

   

Nuciferine

4H-DIBENZO(DE,G)QUINOLINE, 5,6,6A,7-TETRAHYDRO-1,2-DIMETHOXY-6-METHYL-, (6AR)-

C19H21NO2 (295.1572)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2317 Nuciferine is a natural product found in Cissampelos pareira, Paliurus hemsleyanus, and other organisms with data available. Nuciferine is an antagonist at 5-HT2A (IC50=478 nM), 5-HT2C (IC50=131 nM), and 5-HT2B (IC50=1 μM), an inverse agonist at 5-HT7 (IC50=150 nM), a partial agonist at D2 (EC50=64 nM), D5 (EC50=2.6 μM) and 5-HT6 (EC50=700 nM), an agonist at 5-HT1A (EC50=3.2 μM) and D4 (EC50=2 μM) receptor. Nuciferine is an antagonist at 5-HT2A (IC50=478 nM), 5-HT2C (IC50=131 nM), and 5-HT2B (IC50=1 μM), an inverse agonist at 5-HT7 (IC50=150 nM), a partial agonist at D2 (EC50=64 nM), D5 (EC50=2.6 μM) and 5-HT6 (EC50=700 nM), an agonist at 5-HT1A (EC50=3.2 μM) and D4 (EC50=2 μM) receptor. Nuciferine is an antagonist at 5-HT2A (IC50=478 nM), 5-HT2C (IC50=131 nM), and 5-HT2B (IC50=1 μM), an inverse agonist at 5-HT7 (IC50=150 nM), a partial agonist at D2 (EC50=64 nM), D5 (EC50=2.6 μM) and 5-HT6 (EC50=700 nM), an agonist at 5-HT1A (EC50=3.2 μM) and D4 (EC50=2 μM) receptor.

   

(+/-)-NUCIFERINE

(+/-)-NUCIFERINE

C19H21NO2 (295.1572)


   
   

Murrayafoline B

Murrayafoline B

C19H21NO2 (295.1572)


   
   
   

Carbazoquinocin A

(S)-2-Methyl-1-(3-methylpentyl)-3H-carbazole-3,4(9H)-dione

C19H21NO2 (295.1572)


   
   

Isomurrayafoline B

Isomurrayafoline B

C19H21NO2 (295.1572)


   

Dothiepin

(E)-Dosulepin

C19H21NS (295.1395)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu); Flow Injection Flow Injection; CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu) CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu)

   

N-Propylnorapomorphine

N-Propylnorapomorphine

C19H21NO2 (295.1572)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

URB602

[1,1-biphenyl]-3-yl-carbamic acid, cyclohexyl ester

C19H21NO2 (295.1572)


URB602 is a selective monoacylglycerol lipase (MGL) inhibitor, which inhibits rat brain MGL with IC50 of 28±4 μM through a noncompetitive mechanism.

   

Pizotifen

Pizotyline

C19H21NS (295.1395)


D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D002491 - Central Nervous System Agents > D000700 - Analgesics Pizotifen (Pizotyline) is a potent 5-HT2 receptor antagonist, with a high affinity for 5-HT1C binding site.

   

MCULE-9212243221

MCULE-9212243221

C14H21N3O4 (295.1532)


   

12-hydroxy-(13betaH)-19,20-dinor-crotalanane-11,15-dione|Crobarbatin|crobarbatine

12-hydroxy-(13betaH)-19,20-dinor-crotalanane-11,15-dione|Crobarbatin|crobarbatine

C15H21NO5 (295.142)


   

Estrone cyanate

Estrone cyanate

C19H21NO2 (295.1572)


   

Noratherosperminine

Noratherosperminine

C19H21NO2 (295.1572)


   

N-methyllaurotetanine

N-methyllaurotetanine

C19H21NO2 (295.1572)


   
   
   

N-coronafacoyl-L-serine

N-coronafacoyl-L-serine

C15H21NO5 (295.142)


   
   

1-(2-Dimethylamino-aethyl)-3-methoxy-phenanthren-4-ol|1-<2-Dimethylamino-aethyl>-3-methoxy-phenanthren-4-ol

1-(2-Dimethylamino-aethyl)-3-methoxy-phenanthren-4-ol|1-<2-Dimethylamino-aethyl>-3-methoxy-phenanthren-4-ol

C19H21NO2 (295.1572)


   

C15H21NO5

NCGC00385487-01_C15H21NO5_

C15H21NO5 (295.142)


   

C14H21N3O4_1-(5,10-Dioxohexahydro-1H,5H-dipyrrolo[1,2-a:1,2-d]pyrazin-5a(6H)-yl)-2-propanyl carbamate

NCGC00380964-01_C14H21N3O4_1-(5,10-Dioxohexahydro-1H,5H-dipyrrolo[1,2-a:1,2-d]pyrazin-5a(6H)-yl)-2-propanyl carbamate

C14H21N3O4 (295.1532)


   

1-(5,10-dioxo-2,3,5a,6,7,8-hexahydro-1H-dipyrrolo[1,2-d:1,2-f]pyrazin-10a-yl)propan-2-yl carbamate

1-(5,10-dioxo-2,3,5a,6,7,8-hexahydro-1H-dipyrrolo[1,2-d:1,2-f]pyrazin-10a-yl)propan-2-yl carbamate

C14H21N3O4 (295.1532)


   

Dosulepin

(E)-Dosulepin

C19H21NS (295.1395)


N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AA - Non-selective monoamine reuptake inhibitors D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators CONFIDENCE Reference Standard (Level 1); HBM4EU - science and policy for a healthy future (https://www.hbm4eu.eu)

   

hydroxydoxepin M1

hydroxydoxepin M1

C19H21NO2 (295.1572)


   

hydroxydoxepin M2

hydroxydoxepin M2

C19H21NO2 (295.1572)


   

hydroxydoxepin M3

hydroxydoxepin M3

C19H21NO2 (295.1572)


   

hydroxydoxepin M4

hydroxydoxepin M4

C19H21NO2 (295.1572)


   

(E)-Herclavine

(2E)-N-[2-(4-methoxyphenyl)ethyl]-N-methyl-3-phenylprop-2-enamide

C19H21NO2 (295.1572)


   

1-(5,10-Dioxohexahydro-1H,5H-dipyrrolo[1,2-a:1,2-d]pyrazin-5a(6H)-yl)-2-propanyl carbamate

1-(5,10-Dioxohexahydro-1H,5H-dipyrrolo[1,2-a:1,2-d]pyrazin-5a(6H)-yl)-2-propanyl carbamate

C14H21N3O4 (295.1532)


   

2-BENZYLOXY-3-TERT-BUTOXYCARBONYLAMINO-PROPIONIC ACID

2-BENZYLOXY-3-TERT-BUTOXYCARBONYLAMINO-PROPIONIC ACID

C15H21NO5 (295.142)


   

2-BENZOXAZOL-2-YL-1-(4-TERTBUTYLPHENYL)ETHANOL

2-BENZOXAZOL-2-YL-1-(4-TERTBUTYLPHENYL)ETHANOL

C19H21NO2 (295.1572)


   

4-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRAZOL-1-YL)BENZONITRILE

4-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRAZOL-1-YL)BENZONITRILE

C16H18BN3O2 (295.1492)


   

7-tert-Butyl 2-ethyl 5,6-dihydroimidazo[1,2-a]pyrazine-2,7(8H)-dicarboxylate

7-tert-Butyl 2-ethyl 5,6-dihydroimidazo[1,2-a]pyrazine-2,7(8H)-dicarboxylate

C14H21N3O4 (295.1532)


   

(2S,3R)-3-((TERT-BUTOXYCARBONYL)AMINO)-2-HYDROXY-4-PHENYLBUTANOIC ACID

(2S,3R)-3-((TERT-BUTOXYCARBONYL)AMINO)-2-HYDROXY-4-PHENYLBUTANOIC ACID

C15H21NO5 (295.142)


   

4-(2-Fluorophenoxy)-1-piperidinecarboxylic acid tert-butyl ester

4-(2-Fluorophenoxy)-1-piperidinecarboxylic acid tert-butyl ester

C16H22FNO3 (295.1584)


   
   

(R)-(+)-5,5-DIPHENYL-4-ISOBUTYL-2-OXAZOLIDINONE

(R)-(+)-5,5-DIPHENYL-4-ISOBUTYL-2-OXAZOLIDINONE

C19H21NO2 (295.1572)


   

(S)-Boc-3-Methoxy-β-Phe-OH

(S)-Boc-3-Methoxy-β-Phe-OH

C15H21NO5 (295.142)


   

boc-(r)-3-amino-3-(2-methoxy-phenyl)-propionic acid

boc-(r)-3-amino-3-(2-methoxy-phenyl)-propionic acid

C15H21NO5 (295.142)


   

(R)-Boc-3-methoxy-β-Phe-OH

(R)-Boc-3-methoxy-β-Phe-OH

C15H21NO5 (295.142)


   

Boc-D-phe(4-OCH3)-OH

Boc-D-phe(4-OCH3)-OH

C15H21NO5 (295.142)


   

methyl 3-[(tert-butoxycarbonyl)amino]-3-(3-hydroxyphenyl)propanoate

methyl 3-[(tert-butoxycarbonyl)amino]-3-(3-hydroxyphenyl)propanoate

C15H21NO5 (295.142)


   

Boc-Ser-OBzl

Boc-Ser-OBzl

C15H21NO5 (295.142)


   

[2-(2,4-dimethoxy-phenyl)-2-oxo-ethyl]-carbamic acid tert-butyl ester

[2-(2,4-dimethoxy-phenyl)-2-oxo-ethyl]-carbamic acid tert-butyl ester

C15H21NO5 (295.142)


   

2-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propylamino]pyridine-3-carboxylic acid

2-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propylamino]pyridine-3-carboxylic acid

C14H21N3O4 (295.1532)


   

Methyl 1-benzyl-3-phenyl-3-pyrrolidinecarboxylate

Methyl 1-benzyl-3-phenyl-3-pyrrolidinecarboxylate

C19H21NO2 (295.1572)


   

[2-(3,4-dimethoxy-phenyl)-2-oxo-ethyl]-carbamic acid tert-butyl ester

[2-(3,4-dimethoxy-phenyl)-2-oxo-ethyl]-carbamic acid tert-butyl ester

C15H21NO5 (295.142)


   

5-tert-butyl 3-ethyl 6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-3,5(4H)-dicarboxylate

5-tert-butyl 3-ethyl 6,7-dihydro-1H-pyrazolo[4,3-c]pyridine-3,5(4H)-dicarboxylate

C14H21N3O4 (295.1532)


   

Boc-D-Tyr(Me)-OH

Boc-D-Tyr(Me)-OH

C15H21NO5 (295.142)


   

Boc-O-methyl-L-tyrosine

Boc-O-methyl-L-tyrosine

C15H21NO5 (295.142)


   

4-BOC-2-(4-FLUOROPHENYL)-2-METHYLMORPHOLINE

4-BOC-2-(4-FLUOROPHENYL)-2-METHYLMORPHOLINE

C16H22FNO3 (295.1584)


   

methyl 1-benzyl-4-phenylpyrrolidine-3-carboxylate

methyl 1-benzyl-4-phenylpyrrolidine-3-carboxylate

C19H21NO2 (295.1572)


   

Benzyl N-Benzylpyrrolidine-3-carboxylate

Benzyl N-Benzylpyrrolidine-3-carboxylate

C19H21NO2 (295.1572)


   

N-Cyclohexylcarbamic acid [1,1-biphenyl]-3-yl ester

N-Cyclohexylcarbamic acid [1,1-biphenyl]-3-yl ester

C19H21NO2 (295.1572)


   

Ethyl 1-(diphenylmethyl)-3-azetidinecarboxylate

Ethyl 1-(diphenylmethyl)-3-azetidinecarboxylate

C19H21NO2 (295.1572)


   

1-[4-[(4-butoxyphenyl)methylideneamino]phenyl]ethanone

1-[4-[(4-butoxyphenyl)methylideneamino]phenyl]ethanone

C19H21NO2 (295.1572)


   

3-N-Boc-Amino-3-(4-methoxyphenyl)propionic acid

3-N-Boc-Amino-3-(4-methoxyphenyl)propionic acid

C15H21NO5 (295.142)


   

Boc-beta-(S)-4-methoxyphenylalanine

Boc-beta-(S)-4-methoxyphenylalanine

C15H21NO5 (295.142)


   

(R)-2-((TERT-BUTOXYCARBONYL)AMINO)-3-(2-METHOXYPHENYL)PROPANOIC ACID

(R)-2-((TERT-BUTOXYCARBONYL)AMINO)-3-(2-METHOXYPHENYL)PROPANOIC ACID

C15H21NO5 (295.142)


   

(S)-(-)-5,5-DIPHENYL-4-ISOBUTYL-2-OXAZOLIDINONE

(S)-(-)-5,5-DIPHENYL-4-ISOBUTYL-2-OXAZOLIDINONE

C19H21NO2 (295.1572)


   

1,3-Dibenzyl-3-pyrrolidinecarboxylic acid

1,3-Dibenzyl-3-pyrrolidinecarboxylic acid

C19H21NO2 (295.1572)


   

(S)-(-)-4-(2-CHLOROPHENYL)-2-HYDROXY-5,5-DIMETHYL-1,3,2-DIOXAPHOSPHORINANE2-OXIDE

(S)-(-)-4-(2-CHLOROPHENYL)-2-HYDROXY-5,5-DIMETHYL-1,3,2-DIOXAPHOSPHORINANE2-OXIDE

C19H21NO2 (295.1572)


   

Boc-D-Tyr-OMe

Boc-D-Tyr-OMe

C15H21NO5 (295.142)


   

Boc-Homo-Tyrosine

Boc-Homo-Tyrosine

C15H21NO5 (295.142)


   

4-Hydroxy tolbutamide

hydroxy tolbutamide-d9

C12H9D9N2O4S (295.1552)


4-Hydroxy tolbutamide is a hydroxylation byproduct of tolbutamide. Tolbutamide is a first generation potassium channel blocker. It is a sulfonylurea oral hypoglycemic drug sold under the brand name Orinase. This drug may be used in the management of type II diabetes if diet alone is not effective. Tolbutamide stimulates the secretion of insulin by the pancreas. [HMDB]

   

3-morpholin-4-yl-1,2-diphenylpropan-1-one

3-morpholin-4-yl-1,2-diphenylpropan-1-one

C19H21NO2 (295.1572)


   

1-benzyl-4-phenylpiperidine-4-carboxylic acid

1-benzyl-4-phenylpiperidine-4-carboxylic acid

C19H21NO2 (295.1572)


   

(2R,3R)-3-((TERT-BUTOXYCARBONYL)AMINO)-2-HYDROXY-4-PHENYLBUTANOIC ACID

(2R,3R)-3-((TERT-BUTOXYCARBONYL)AMINO)-2-HYDROXY-4-PHENYLBUTANOIC ACID

C15H21NO5 (295.142)


   

Oxitriptyline

Oxitriptyline

C19H21NO2 (295.1572)


   
   

2-((TERT-BUTOXYCARBONYL)AMINO)-3-(4-METHOXYPHENYL)PROPANOIC ACID

2-((TERT-BUTOXYCARBONYL)AMINO)-3-(4-METHOXYPHENYL)PROPANOIC ACID

C15H21NO5 (295.142)


   

boc-(s)-3-amino-3-(2-methoxy-phenyl)-propionic acid

boc-(s)-3-amino-3-(2-methoxy-phenyl)-propionic acid

C15H21NO5 (295.142)


   

N-Boc-O-Benzyl-D-serine

N-Boc-O-Benzyl-D-serine

C15H21NO5 (295.142)


   

3-(boc-amino)-3-(3-methoxyphenyl)propionic acid

3-(boc-amino)-3-(3-methoxyphenyl)propionic acid

C15H21NO5 (295.142)


   

boc-n-me-tyr-oh

boc-n-me-tyr-oh

C15H21NO5 (295.142)


   

Boc-Ser(Bzl)-OH

Boc-Ser(Bzl)-OH

C15H21NO5 (295.142)


   

N-(tert-Butoxycarbonyl)-3-methoxy-D-phenylalanine

N-(tert-Butoxycarbonyl)-3-methoxy-D-phenylalanine

C15H21NO5 (295.142)


   

5-(2,1,3-benzoxadiazol-5-yl)-N-cyclopentyl-2-methylpyrimidin-4-amine

5-(2,1,3-benzoxadiazol-5-yl)-N-cyclopentyl-2-methylpyrimidin-4-amine

C16H17N5O (295.1433)


   

tert-Butyl 2-((diphenylmethylene)amino)acetate

tert-Butyl 2-((diphenylmethylene)amino)acetate

C19H21NO2 (295.1572)


   

(4-(Benzyloxy)phenyl)(piperidin-4-yl)Methanone

(4-(Benzyloxy)phenyl)(piperidin-4-yl)Methanone

C19H21NO2 (295.1572)


   

ethyl 1-benzhydrylazetidine-2-carboxylate

ethyl 1-benzhydrylazetidine-2-carboxylate

C19H21NO2 (295.1572)


   

Boc-L-Tyrosine methyl ester

Boc-L-Tyrosine methyl ester

C15H21NO5 (295.142)


   

P,P-di(aziridin-1-yl)-N-(2-(diethylamino)pyridin-4-yl)phosphinic amide

P,P-di(aziridin-1-yl)-N-(2-(diethylamino)pyridin-4-yl)phosphinic amide

C13H22N5OP (295.1562)


   

H-Glu(OtBu)-OtBu.HCl

H-Glu(OtBu)-OtBu.HCl

C13H26ClNO4 (295.155)


   

Boc-D-Ser-O-Bzl

Boc-D-Ser-O-Bzl

C15H21NO5 (295.142)


   

Beloxepin

Beloxepin

C19H21NO2 (295.1572)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

3-Allyl-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine

3-Allyl-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine

C19H21NO2 (295.1572)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

6-[4-(Methylthio)phenyl]-1,2,3,5,6,10b-hexahydropyrrolo[2,1-a]isoquinoline

Pyrrolo(2,1-a)isoquinoline, 1,2,3,5,6,10b-hexahydro-6-(4-(methylthio)phenyl)-, (6R,10bS)-

C19H21NS (295.1395)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists

   

(6aS)-6-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol

(6aS)-6-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol

C19H21NO2 (295.1572)


   

3,4-dihydro-2H-quinolin-1-yl-(4-propoxyphenyl)methanone

3,4-dihydro-2H-quinolin-1-yl-(4-propoxyphenyl)methanone

C19H21NO2 (295.1572)


   

1-(2,5-Dideoxy-5-Pyrrolidin-1-Yl-Beta-L-Erythro-Pentofuranosyl)-5-Methylpyrimidine-2,4(1h,3h)-Dione

1-(2,5-Dideoxy-5-Pyrrolidin-1-Yl-Beta-L-Erythro-Pentofuranosyl)-5-Methylpyrimidine-2,4(1h,3h)-Dione

C14H21N3O4 (295.1532)


   

Nuciferin

4H-Dibenzo(de,g)quinoline, 5,6,6a,7-tetrahydro-1,2-dimethoxy-6-methyl-, (R)- (9CI)

C19H21NO2 (295.1572)


Nuciferine is an antagonist at 5-HT2A (IC50=478 nM), 5-HT2C (IC50=131 nM), and 5-HT2B (IC50=1 μM), an inverse agonist at 5-HT7 (IC50=150 nM), a partial agonist at D2 (EC50=64 nM), D5 (EC50=2.6 μM) and 5-HT6 (EC50=700 nM), an agonist at 5-HT1A (EC50=3.2 μM) and D4 (EC50=2 μM) receptor. Nuciferine is an antagonist at 5-HT2A (IC50=478 nM), 5-HT2C (IC50=131 nM), and 5-HT2B (IC50=1 μM), an inverse agonist at 5-HT7 (IC50=150 nM), a partial agonist at D2 (EC50=64 nM), D5 (EC50=2.6 μM) and 5-HT6 (EC50=700 nM), an agonist at 5-HT1A (EC50=3.2 μM) and D4 (EC50=2 μM) receptor. Nuciferine is an antagonist at 5-HT2A (IC50=478 nM), 5-HT2C (IC50=131 nM), and 5-HT2B (IC50=1 μM), an inverse agonist at 5-HT7 (IC50=150 nM), a partial agonist at D2 (EC50=64 nM), D5 (EC50=2.6 μM) and 5-HT6 (EC50=700 nM), an agonist at 5-HT1A (EC50=3.2 μM) and D4 (EC50=2 μM) receptor.

   

Psb 11 hydrochloride

Psb 11 hydrochloride

C16H17N5O (295.1433)


   

2-Methoxy-4-[(4-methyl-1,4-diazepan-1-yl)methyl]-6-nitrophenol

2-Methoxy-4-[(4-methyl-1,4-diazepan-1-yl)methyl]-6-nitrophenol

C14H21N3O4 (295.1532)


   

4-amino-2,6-dimethyl-5-[3-(4-methylphenyl)-1H-pyrazol-5-yl]-3-pyridazinone

4-amino-2,6-dimethyl-5-[3-(4-methylphenyl)-1H-pyrazol-5-yl]-3-pyridazinone

C16H17N5O (295.1433)


   

6-(2,3-Dihydroxy-3-methylbutoxy)-4-methoxy-5-methyl-2,3-dihydroisoindol-1-one

6-(2,3-Dihydroxy-3-methylbutoxy)-4-methoxy-5-methyl-2,3-dihydroisoindol-1-one

C15H21NO5 (295.142)


   

N-(2-oxolanylmethyl)-1-phenyl-4-pyrazolo[3,4-d]pyrimidinamine

N-(2-oxolanylmethyl)-1-phenyl-4-pyrazolo[3,4-d]pyrimidinamine

C16H17N5O (295.1433)


   

3-[3-(4-isopropylphenyl)acryloyl]-4,6-dimethyl-2(1H)-pyridinone

3-[3-(4-isopropylphenyl)acryloyl]-4,6-dimethyl-2(1H)-pyridinone

C19H21NO2 (295.1572)


   

1-(4-methylphenyl)-5-[(4-morpholinylmethylene)amino]-1H-pyrazole-4-carbonitrile

1-(4-methylphenyl)-5-[(4-morpholinylmethylene)amino]-1H-pyrazole-4-carbonitrile

C16H17N5O (295.1433)


   

N-butyl-N(2)-[(2Z)-2-(2-furyl)-2-(methoxyimino)acetyl]-L-alaninamide

N-butyl-N(2)-[(2Z)-2-(2-furyl)-2-(methoxyimino)acetyl]-L-alaninamide

C14H21N3O4 (295.1532)


   

4-{[(2S,5S)-5-[(4-hydroxyphenyl)methyl]-2,5-dihydropyrazin-2-yl]methyl}phenol

4-{[(2S,5S)-5-[(4-hydroxyphenyl)methyl]-2,5-dihydropyrazin-2-yl]methyl}phenol

C18H19N2O2+ (295.1446)


   

N,N-Dibutyl-2,4-dinitrobenzenamine

N,N-Dibutyl-2,4-dinitrobenzenamine

C14H21N3O4 (295.1532)


   

N,N-Diisobutyl-2,4-dinitrobenzenamine

N,N-Diisobutyl-2,4-dinitrobenzenamine

C14H21N3O4 (295.1532)


   
   

2-[[2-(4-Hydroxyphenyl)ethylamino]methyl]-3,4-dihydro-2H-naphthalen-1-one

2-[[2-(4-Hydroxyphenyl)ethylamino]methyl]-3,4-dihydro-2H-naphthalen-1-one

C19H21NO2 (295.1572)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists

   

(E)-2-hydroxydoxepin

(E)-2-hydroxydoxepin

C19H21NO2 (295.1572)


   

Doxepin N-oxide

Doxepin N-oxide

C19H21NO2 (295.1572)


   

(8R)-7-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-13,14-diol

(8R)-7-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-13,14-diol

C19H21NO2 (295.1572)


   

Pyrrolo(2,1-a)isoquinoline, 1,2,3,5,6,10b-hexahydro-6-(4-(methylthio)phenyl)-, (6R,10bS)-

Pyrrolo(2,1-a)isoquinoline, 1,2,3,5,6,10b-hexahydro-6-(4-(methylthio)phenyl)-, (6R,10bS)-

C19H21NS (295.1395)


   

(6S,10bR)-6-[4-(methylthio)phenyl]-1,2,3,5,6,10b-hexahydropyrrolo[2,1-a]isoquinoline

(6S,10bR)-6-[4-(methylthio)phenyl]-1,2,3,5,6,10b-hexahydropyrrolo[2,1-a]isoquinoline

C19H21NS (295.1395)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists

   

NA-DOPA 6:0

NA-DOPA 6:0

C15H21NO5 (295.142)


   

Dopamine D2 receptor agonist-3

Dopamine D2 receptor agonist-3

C15H22ClN3O (295.1451)


Dopamine D2 receptor agonist-3 (compound 3) is a selective D2 receptor partial agonist and Dopamine D3 receptor antagonist (with pEC50 of 8.3 and <5.5 respectively)[1].

   

6-hydroxy-4-{3-[(3r,5s)-5-(hydroxymethyl)-3,5-dimethyloxolan-2-ylidene]-2-oxopropyl}-4,5-dihydro-3h-pyridin-2-one

6-hydroxy-4-{3-[(3r,5s)-5-(hydroxymethyl)-3,5-dimethyloxolan-2-ylidene]-2-oxopropyl}-4,5-dihydro-3h-pyridin-2-one

C15H21NO5 (295.142)


   

2,2-dimethyl-7-(2-methylbut-3-en-2-yl)-8h-chromeno[7,6-b]pyrrole-6-carbaldehyde

2,2-dimethyl-7-(2-methylbut-3-en-2-yl)-8h-chromeno[7,6-b]pyrrole-6-carbaldehyde

C19H21NO2 (295.1572)


   

(1r,5r,6s,16r)-6-hydroxy-5,6-dimethyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

(1r,5r,6s,16r)-6-hydroxy-5,6-dimethyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

C15H21NO5 (295.142)


   

6-hydroxy-4-{[5-(3-hydroxy-2-methylpropyl)-5-methyl-4-oxofuran-2-yl]methyl}-4,5-dihydro-3h-pyridin-2-one

6-hydroxy-4-{[5-(3-hydroxy-2-methylpropyl)-5-methyl-4-oxofuran-2-yl]methyl}-4,5-dihydro-3h-pyridin-2-one

C15H21NO5 (295.142)


   

(7-oxo-5,6-dihydropyrrolizin-1-yl)methyl 2,3-dihydroxy-2-isopropylbutanoate

(7-oxo-5,6-dihydropyrrolizin-1-yl)methyl 2,3-dihydroxy-2-isopropylbutanoate

C15H21NO5 (295.142)


   

2-methyl-1-[(3s)-3-methylpentyl]-9h-carbazole-3,4-dione

2-methyl-1-[(3s)-3-methylpentyl]-9h-carbazole-3,4-dione

C19H21NO2 (295.1572)


   

6-hydroxy-4-{[(5s,6s)-6-[(2r)-1-hydroxypropan-2-yl]-5-methyl-4-oxo-5,6-dihydropyran-2-yl]methyl}-4,5-dihydro-3h-pyridin-2-one

6-hydroxy-4-{[(5s,6s)-6-[(2r)-1-hydroxypropan-2-yl]-5-methyl-4-oxo-5,6-dihydropyran-2-yl]methyl}-4,5-dihydro-3h-pyridin-2-one

C15H21NO5 (295.142)


   

6-hydroxy-4-{[6-(1-hydroxypropan-2-yl)-5-methyl-4-oxo-5,6-dihydropyran-2-yl]methyl}-4,5-dihydro-3h-pyridin-2-one

6-hydroxy-4-{[6-(1-hydroxypropan-2-yl)-5-methyl-4-oxo-5,6-dihydropyran-2-yl]methyl}-4,5-dihydro-3h-pyridin-2-one

C15H21NO5 (295.142)


   

6-hydroxy-4-{[(5r)-5-[(2s)-3-hydroxy-2-methylpropyl]-5-methyl-4-oxofuran-2-yl]methyl}-4,5-dihydro-3h-pyridin-2-one

6-hydroxy-4-{[(5r)-5-[(2s)-3-hydroxy-2-methylpropyl]-5-methyl-4-oxofuran-2-yl]methyl}-4,5-dihydro-3h-pyridin-2-one

C15H21NO5 (295.142)


   

3-[(2z)-4-[4-hydroxy-4-(hydroxymethyl)cyclohexyl]-5-oxofuran-2-ylidene]-2-methylpropanimidic acid

3-[(2z)-4-[4-hydroxy-4-(hydroxymethyl)cyclohexyl]-5-oxofuran-2-ylidene]-2-methylpropanimidic acid

C15H21NO5 (295.142)


   

1-[8-hydroxy-1,3-bis(hydroxymethyl)-7-methoxy-6-methyl-3,4-dihydro-1h-isoquinolin-2-yl]ethanone

1-[8-hydroxy-1,3-bis(hydroxymethyl)-7-methoxy-6-methyl-3,4-dihydro-1h-isoquinolin-2-yl]ethanone

C15H21NO5 (295.142)


   

7-methoxy-3-methyl-8-(3-methylbut-2-en-1-yl)-9h-carbazol-1-ol

7-methoxy-3-methyl-8-(3-methylbut-2-en-1-yl)-9h-carbazol-1-ol

C19H21NO2 (295.1572)


   

1-hydroxy-11-(4-hydroxyphenyl)-3-methyl-6h,7h,8h,9h-10λ⁵-pyridazino[1,2-a]indazol-10-ylium

1-hydroxy-11-(4-hydroxyphenyl)-3-methyl-6h,7h,8h,9h-10λ⁵-pyridazino[1,2-a]indazol-10-ylium

[C18H19N2O2]+ (295.1446)


   

5-(acetyloxy)-3-methyl-n-(2,4,5-trimethyl-3-oxofuran-2-yl)pent-2-enimidic acid

5-(acetyloxy)-3-methyl-n-(2,4,5-trimethyl-3-oxofuran-2-yl)pent-2-enimidic acid

C15H21NO5 (295.142)


   

(7-oxo-5,6-dihydropyrrolizin-1-yl)methyl (2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

(7-oxo-5,6-dihydropyrrolizin-1-yl)methyl (2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate

C15H21NO5 (295.142)


   

(9s)-5-isopropyl-9-methyl-15-azatetracyclo[7.6.1.0²,⁶.0¹³,¹⁶]hexadeca-1,4,6,13(16)-tetraene-3,14-dione

(9s)-5-isopropyl-9-methyl-15-azatetracyclo[7.6.1.0²,⁶.0¹³,¹⁶]hexadeca-1,4,6,13(16)-tetraene-3,14-dione

C19H21NO2 (295.1572)


   

2-{[(6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl)(hydroxy)methylidene]amino}-3-hydroxypropanoic acid

2-{[(6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl)(hydroxy)methylidene]amino}-3-hydroxypropanoic acid

C15H21NO5 (295.142)


   

n-[2-(4-methoxyphenyl)ethyl]-n-methyl-3-phenylprop-2-enamide

n-[2-(4-methoxyphenyl)ethyl]-n-methyl-3-phenylprop-2-enamide

C19H21NO2 (295.1572)


   

1-[(1r,3s)-8-hydroxy-1,3-bis(hydroxymethyl)-7-methoxy-6-methyl-3,4-dihydro-1h-isoquinolin-2-yl]ethanone

1-[(1r,3s)-8-hydroxy-1,3-bis(hydroxymethyl)-7-methoxy-6-methyl-3,4-dihydro-1h-isoquinolin-2-yl]ethanone

C15H21NO5 (295.142)


   

{4-hydroxy-2-oxo-hexahydro-3h-furo[3,2-a]pyrrolizin-3a-yl}methyl 3-methylbut-2-enoate

{4-hydroxy-2-oxo-hexahydro-3h-furo[3,2-a]pyrrolizin-3a-yl}methyl 3-methylbut-2-enoate

C15H21NO5 (295.142)


   

[2-(3,4-dimethoxyphenanthren-1-yl)ethyl](methyl)amine

[2-(3,4-dimethoxyphenanthren-1-yl)ethyl](methyl)amine

C19H21NO2 (295.1572)


   

(9s)-15,16-dimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaene

(9s)-15,16-dimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaene

C19H21NO2 (295.1572)


   

n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}-2-methylpropanamide

n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}-2-methylpropanamide

C14H21N3O4 (295.1532)


   

(2e)-5-(acetyloxy)-3-methyl-n-[(2s)-2,4,5-trimethyl-3-oxofuran-2-yl]pent-2-enimidic acid

(2e)-5-(acetyloxy)-3-methyl-n-[(2s)-2,4,5-trimethyl-3-oxofuran-2-yl]pent-2-enimidic acid

C15H21NO5 (295.142)


   

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]-2-methylpropanamide

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]-2-methylpropanamide

C14H21N3O4 (295.1532)


   

[(3ar,3br,4r,8ar)-4-hydroxy-2-oxo-hexahydro-3h-furo[3,2-a]pyrrolizin-3a-yl]methyl 3-methylbut-2-enoate

[(3ar,3br,4r,8ar)-4-hydroxy-2-oxo-hexahydro-3h-furo[3,2-a]pyrrolizin-3a-yl]methyl 3-methylbut-2-enoate

C15H21NO5 (295.142)


   

n-(2-{4-[(2-methylprop-1-en-1-yl)oxy]phenyl}ethyl)benzenecarboximidic acid

n-(2-{4-[(2-methylprop-1-en-1-yl)oxy]phenyl}ethyl)benzenecarboximidic acid

C19H21NO2 (295.1572)


   

6-hydroxy-4-{3-[5-(hydroxymethyl)-3,5-dimethyloxolan-2-ylidene]-2-oxopropyl}-4,5-dihydro-3h-pyridin-2-one

6-hydroxy-4-{3-[5-(hydroxymethyl)-3,5-dimethyloxolan-2-ylidene]-2-oxopropyl}-4,5-dihydro-3h-pyridin-2-one

C15H21NO5 (295.142)


   

3-{4-[4-hydroxy-4-(hydroxymethyl)cyclohexyl]-5-oxofuran-2-ylidene}-2-methylpropanimidic acid

3-{4-[4-hydroxy-4-(hydroxymethyl)cyclohexyl]-5-oxofuran-2-ylidene}-2-methylpropanimidic acid

C15H21NO5 (295.142)


   

(2s)-2-({[(3as,6r,7as)-6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl](hydroxy)methylidene}amino)-3-hydroxypropanoic acid

(2s)-2-({[(3as,6r,7as)-6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl](hydroxy)methylidene}amino)-3-hydroxypropanoic acid

C15H21NO5 (295.142)


   

(2e)-5-(acetyloxy)-3-methyl-n-[(2r)-2,4,5-trimethyl-3-oxofuran-2-yl]pent-2-enimidic acid

(2e)-5-(acetyloxy)-3-methyl-n-[(2r)-2,4,5-trimethyl-3-oxofuran-2-yl]pent-2-enimidic acid

C15H21NO5 (295.142)


   

2,2-dimethyl-7-(2-methylbut-3-en-2-yl)chromeno[7,6-b]pyridin-8-ol

2,2-dimethyl-7-(2-methylbut-3-en-2-yl)chromeno[7,6-b]pyridin-8-ol

C19H21NO2 (295.1572)


   

2-[2-(2h-1,3-benzodioxol-5-yl)ethyl]-1-methyl-3,4-dihydro-2h-quinoline

2-[2-(2h-1,3-benzodioxol-5-yl)ethyl]-1-methyl-3,4-dihydro-2h-quinoline

C19H21NO2 (295.1572)


   

1-[2-(dimethylamino)ethyl]-4-methoxyphenanthren-3-ol

1-[2-(dimethylamino)ethyl]-4-methoxyphenanthren-3-ol

C19H21NO2 (295.1572)


   

(2s)-2-[2-(2h-1,3-benzodioxol-5-yl)ethyl]-1-methyl-3,4-dihydro-2h-quinoline

(2s)-2-[2-(2h-1,3-benzodioxol-5-yl)ethyl]-1-methyl-3,4-dihydro-2h-quinoline

C19H21NO2 (295.1572)


   

1-(2,4-dihydroxy-5,6-dimethoxypyridin-3-yl)-2,4-dimethylhex-5-en-1-one

1-(2,4-dihydroxy-5,6-dimethoxypyridin-3-yl)-2,4-dimethylhex-5-en-1-one

C15H21NO5 (295.142)


   

6-hydroxy-5,6-dimethyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

6-hydroxy-5,6-dimethyl-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-ene-3,7-dione

C15H21NO5 (295.142)


   

6-hydroxy-4-{3-[(3r,5r)-5-(hydroxymethyl)-3,5-dimethyloxolan-2-ylidene]-2-oxopropyl}-4,5-dihydro-3h-pyridin-2-one

6-hydroxy-4-{3-[(3r,5r)-5-(hydroxymethyl)-3,5-dimethyloxolan-2-ylidene]-2-oxopropyl}-4,5-dihydro-3h-pyridin-2-one

C15H21NO5 (295.142)


   

6-methoxy-3-methyl-5-(3-methylbut-2-en-1-yl)-9h-carbazol-2-ol

6-methoxy-3-methyl-5-(3-methylbut-2-en-1-yl)-9h-carbazol-2-ol

C19H21NO2 (295.1572)


   

7-methoxy-3-methyl-8-(3-methylbut-2-en-1-yl)-9h-carbazol-2-ol

7-methoxy-3-methyl-8-(3-methylbut-2-en-1-yl)-9h-carbazol-2-ol

C19H21NO2 (295.1572)


   

2-methyl-1-(3-methylpentyl)-9h-carbazole-3,4-dione

2-methyl-1-(3-methylpentyl)-9h-carbazole-3,4-dione

C19H21NO2 (295.1572)